Myelodysplastic syndromes (MDS) are a group of haematological disorders that occur primarily in people over the age of 70. There are various guidelines for the diagnosis and treatment of MDS, but it is unknown how well these guidelines are followed in clinical practice and whether there is any resulting benefit for patients.

For more information on where and how this trial is conducted, consult the trial website.